Pharmacokinetics and tolerability of subcutaneous dupilumab coformulated with berahyaluronidase alfa and dupilumab without berahyaluronidase alfa in healthy participants

Trial Identifier:	PKM20425
Sponsor:	Sanofi
Collaborator:	Regeneron Pharmaceuticals
Start Date:	June 2026
Primary Completion Date:	September 2026
Study Completion Date:	September 2026
Condition:	Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United States	United States

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.